文献速递重症综合管理与镇静镇痛中毒与环境急症心脑血管急症

脑死亡判定中的药理学与毒理学混杂因素:多学科指南

Pharmacologic and toxicologic confounders in brain death determination: a multidisciplinary guide.
PubMed 文献 · Crit Care · 2026-01-20
一句话结论综述指出脑死亡判定常受药物与毒物混杂因素干扰,现行指南未充分涵盖药代/药效改变,需神经、药学、重症与毒理多学科协作以减少过早判定。

该综述聚焦ICU昏迷患者脑死亡判定中的药理学与毒理学混杂因素。文章指出器官衰竭、低体温、持续输注、中毒和极度肥胖常改变药物代谢与清除,而指南推荐常未考虑药代/药效改变。常规毒理筛查并不全面,低体温与多器官功能障碍进一步降低药物清除;辅助检查在深度中毒时有局限,过早使用可致误判。作者强调昏迷与脑死亡评估需神经、药学、重症与毒理多学科整合,并呼吁进一步研究以提高诊断准确性、降低过早脑死亡判定的风险。

要点

  • 器官衰竭、低体温、持续输注、中毒和极度肥胖常改变药物代谢与清除,指南推荐常未考虑这些药代/药效改变。
  • 药物性昏迷预后通常优于其他病因,但需尽早确定药物性昏迷的病因以争取最佳结局。
  • 常规毒理筛查并不全面;低体温通过影响肝代谢降低药物清除,使判定更复杂。
  • 辅助检查在深度中毒时有局限,过早使用辅助检查可能导致误判。
  • 昏迷与脑死亡准确评估常需神经、药学、重症与毒理多学科协作,现行指南在药物/毒物混杂因素上仍存关键空白。

适用人群与场景

  • ICU中昏迷患者,包括需脑死亡判定者;合并器官衰竭、低体温、持续输注、中毒或极度肥胖者药物代谢与清除常改变。

处置流程与药物剂量

  • 昏迷评估需准确区分药理学、代谢性与结构性病因,药物性昏迷一般预后更有利,但应尽早确定药物性昏迷的病因以争取最佳结局。
  • 脑死亡判定时应考虑药代/药效改变;辅助检查可用于诊断但存在局限,深度中毒时尤其明显,过早使用辅助检查可能导致误判。
  • 昏迷与脑死亡评估常需多学科协作,整合神经科、药学、重症与毒理学专业。

红旗征与不能漏的情况

  • 深度中毒时辅助检查有局限,过早使用辅助检查可能导致误判。
  • 常规毒理筛查不全面,可能遗漏导致昏迷的药物/毒物。

研究设计与关键结果

  • 综述分为两部分:第一部分讨论一般昏迷及其药理学考量,第二部分聚焦脑死亡。
  • 文章指出器官衰竭、低体温、持续输注、中毒和极度肥胖常改变药物代谢与清除,指南推荐常未考虑药代/药效改变。
  • 常规毒理筛查不全面;低体温显著影响肝代谢等药代参数,降低药物清除;严重神经损伤后多器官功能障碍进一步增加评估难度。
  • 辅助检查在深度中毒时有局限,过早使用辅助检查可能导致误判。
  • 结论强调多学科协作与进一步研究以细化诊断准确性、降低过早脑死亡判定的风险。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对ICU昏迷患者,尤其合并器官衰竭、低体温、持续输注、中毒或极度肥胖者,脑死亡判定前应考虑药代/药效改变对评估的影响。
  • 不应依赖常规毒理筛查排除药物性昏迷;深度中毒时辅助检查结果需谨慎解读,避免过早使用辅助检查导致误判。
  • 作者认为昏迷与脑死亡评估常需神经、药学、重症与毒理多学科协作,并需进一步研究以细化诊断准确性、降低过早脑死亡判定风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The assessment of comatose ICU patients presents several challenges with respect to the etiology, depth and ultimate outcome. The acceptance in 1959 of the worst-outcome scenarios of coma, i.e. brain death, and the publication of the Harvard Brain Death Criteria in 1968, were key developments in the management of irreversible coma. Pharmacologic confounders often complicate coma assessments, including brain-death determination. Moreover, associated clinical factors during coma, such as organ failure, hypothermia, prolonged continuous infusions, intoxication, and extreme obesity often alter drug metabolism and clearance. Such circumstances may further complicate standard assessments, and guideline recommendations often do not account for altered pharmacokinetics and pharmacodynamics.

MAIN TEXT: The assessment of comatose patients involves complex pharmacologic considerations that significantly impact diagnostic accuracy. Accurate differentiation between pharmacologic, metabolic, and structural causes of coma is essential, particularly since drug-related unconsciousness generally carries a more favorable prognosis than other etiologies. Nonetheless, for best outcomes, it is imperative that the etiology of any drug-induced coma be determined as early as possible. It is important to recognize, however, that routine toxicology screens are not comprehensive. Additionally, the interplay between hypothermia and drug metabolism poses unique challenges, as core temperature significantly affects pharmacokinetic parameters such as hepatic metabolism, leading to reduced drug clearance. Multiorgan dysfunction, common after severe neurological injury, further complicates these assessments. Overdose scenarios introduce additional complexity. While ancillary testing may aid in diagnosis of brain death, they have limitations, particularly in cases of profound intoxication. Additionally, premature use of ancillary testing could lead to misdiagnosis. This review is organized into two main sections: Part I examines general coma and its associated pharmacologic considerations, followed by Part II which focuses on brain death.

CONCLUSION: Accurate assessment of coma and brain death often requires a multidisciplinary approach, integrating expertise in neurology, pharmacy, critical care, and toxicology. Current brain death guidelines provide a framework but leave open critical gaps in pharmacologic and toxicologic confounders. This review article highlights the importance of multidisciplinary approach to the care of coma and brain death patients and further research to refine diagnostic accuracy and mitigate the risks of premature brain death declarations.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Farrokh S, Cook A, Feldman R, et al. Pharmacologic and toxicologic confounders in brain death determination: a multidisciplinary guide. Crit Care. 2026. PMID: 41559743. doi:10.1186/s13054-025-05833-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。